[Progress and prospect of clinical application of anti-rabies virus monoclonal antibody preparation].

Lyu, X J; Dong, G M; Liu, X Q; Liu, S; Liu, C; Chen, Q J; Yin, W W; Wang, C L

Lyu, X J; Dong, G M; Liu, X Q; Liu, S; Liu, C; Chen, Q J; Yin, W W; Wang, C L.

Afiliação

Lyu XJ; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Dong GM; Department of Arboviruses and Rabies, National Institutes for Food and Drug Control, Beijing 102629, China.
Liu XQ; Center of Vaccine Clinical Research, Yunnan Center for Disease Control and Prevention, Kunming 650034, China.
Liu S; Emergency Department, Peking University First Hospital, Beijing 100034, China.
Liu C; Emergency Department, Peking University First Hospital, Beijing 100034, China.
Chen QJ; Emergency Department, Beijing Hepingli Hospital, Beijing 100013, China.
Yin WW; Infectious Disease Management Department, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Wang CL; Emergency Department/Trauma Center, Peking University People's Hospital, Beijing 100044, China.

Zhonghua Yi Xue Za Zhi ; 103(32): 2475-2479, 2023 Aug 29.

Article em Zh | MEDLINE | ID: mdl-37491162

Assuntos

Vacina Antirrábica; Vírus da Raiva; Raiva; Humanos; Raiva/prevenção & controle; Imunossupressores; Anticorpos Monoclonais/uso terapêutico; Anticorpos Antivirais

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Raiva / Vírus da Raiva / Vacina Antirrábica Tipo de estudo: Clinical_trials Limite: Humans Idioma: Zh Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google